Afficher la couverture '[Medical therapies for hepatocellular carcinoma]. | Merle, Philippe' en grand format
/5

0 avis

[Medical therapies for hepatocellular carcinoma].

Archive ouverte

Merle, Philippe | Mornex, F.

Edité par CCSD ; Elsevier Masson -

International audience. Medical therapies for hepatocellular carcinoma are limited. Standard antimitotic chemotherapies and hormonotherapies are inefficient. Only sorafenib, an antiangiogenic agent inhibiting the VEGF and PDGF receptors as well as MAP kinase pathway, has shown a significant benefit on patient survival. However, its indication is restricted to patients with multifocal hepatocellular carcinoma not responding to transarterial hepatic chemoembolization or patients with hepatocellular carcinoma invading the venous portal tract or spreading to lymph nodes or as distant visceral metastasis.

Consulter en ligne

Suggestions

Du même auteur

[Transarterial chemoembolization and conformal radiotherapy for hepatocellular carcinoma].

Archive ouverte | Merle, Philippe | CCSD

International audience. Hepatocellular carcinoma is a poor prognosis tumour. The potential curative therapeutic options are orthotopic liver transplantation, surgical resection and radiofrequency ablation. Unfortuna...

[A complete issue devoted entirely to hepatocellular carcinoma?].

Archive ouverte | Mornex, F. | CCSD

International audience

Feasibility of pre-operative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial

Archive ouverte | Mornex, F. | CCSD

Chargement des enrichissements...